Table 1 Characteristics of included studies
From: Systematic review with network meta-analysis: dual therapy for high-risk bleeding peptic ulcers
Author (Year) | Country | Comparison | No. of Patients | Rebleeding (%) | Surgery (%) | Mortality (%) | Complication (%) |
|---|---|---|---|---|---|---|---|
Treatment/Control | Treatment/Control | Treatment/Control | Treatment/Control | Treatment/Control | |||
Balanzo (1990) [21] | Spain | Epi + Thromb vs Epi | 32/32 | 6/13 | 16/13 | 0/0 | NR/NR |
Pescatore (2002) [20] | Switzerland | Epi + Thromb vs Epi | 65/70 | 22/24 | 6/10 | 3/3 | 2/1 |
Lin (1999) [33] | Taiwan, China | Epi + Therm vs Epi | 32/32 | 6/34 | 3/16 | 3/9 | 0/0 |
Park (2004) [9] | Korea | Epi + Mech vs Epi | 45/45 | 4/20 | 2/4 | 0/2 | NR/NR |
Kubba (1996) [19] | Scotland | Epi + Thromb vs Epi | 70/70 | 4/20 | 4/7 | 0/10 | 0/0 |
Chung (1996) [26] | HongKong, China | Epi + Scler vs Epi | 79/81 | 8/11 | 11/15 | 9/5 | NR/NR |
Lin (1993) [24] | Taiwan, China | Epi + Scler vs Epi | 32/32 | 16/34 | 6/3 | 6/0 | 0/0 |
Chung (1993) [25] | HongKong, China | Epi + Scler vs Epi | 98/98 | 11/9 | 14/16 | 4/9 | 1/0 |
Lo (2006) [13] | Taiwan, China | Epi + Mech vs Epi | 52/53 | 4/21 | 0/9 | 2/0 | 0/0 |
Chung (1999) [22] | Korea | Epi + Mech vs Epi | 42/41 | 10/15 | 2/15 | 2/2 | 0/7 |
Rutgeerts (1989) [30] | Belgium | Epi + Scler vs Epi | 40/40 | 18/40 | 8/15 | 5/10 | 4/0 |
Villanueva (1993) [27] | Spain | Epi + Scler vs Epi | 33/30 | 21/10 | 15/13 | 3/6 | 3/0 |
Sollano (1991) [28] | Philippines | Epi + Scler vs Epi | 29/32 | 7/6 | 0/3 | 0/3 | 3/0 |
Garrido (2002) [31] | Spain | Epi + Scler vs Epi | 40/45 | 8/27 | NR/NR | NR/NR | NR/NR |
Choudari (1994) [29] | England | Epi + Scler vs Epi | 52/55 | 13/15 | 8/7 | 0/2 | NR/NR |
Taghavi (2009) [23] | Iran | Epi + Therm vs Epi + Mech | 89/83 | 11/5 | 2/0 | 2/1 | 0/0 |
Chung (1997) [32] | HongKong, China | Epi + Therm vs Epi | 136/134 | 4/9 | 6/10 | 6/5 | 1/0 |